Register entry

Catalent Micron Technologies Limited

Data as of · How to read this entry

Registered sites
0
Active NDC listings
49
Labeller names
3
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

49

49 active NDC listings: 49 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 49.

Dosage formNDCs
powder49
RouteNDCs
Labeller name on the listingNDCs
catalent micron technologies, inc.41
catalent micron technologies ltd7
catalent micron technologies limited1
Catalogue

Marketed products

49
BrandGeneric nameForm / routeNDC
-Abiraterone Acetatepowder69988-0011DRUG FOR FURTHER PROCESSING
-Acetaminophenpowder69988-0024DRUG FOR FURTHER PROCESSING
-Acyclovirpowder69988-0027DRUG FOR FURTHER PROCESSING
-Albuterol Sulphatepowder69988-0064DRUG FOR FURTHER PROCESSING
-Alectinibpowder69988-0047DRUG FOR FURTHER PROCESSING
-Anastrozolepowder69988-0013DRUG FOR FURTHER PROCESSING
-Apixabanpowder69989-0006DRUG FOR FURTHER PROCESSING
-Belumosudilpowder69988-0056DRUG FOR FURTHER PROCESSING
-Bendroflumethiazidepowder69988-0028DRUG FOR FURTHER PROCESSING
-Bexarotenepowder69988-0006DRUG FOR FURTHER PROCESSING
-Clonidinepowder69988-0033DRUG FOR FURTHER PROCESSING
-Dantrolene Sodiumpowder69988-0029DRUG FOR FURTHER PROCESSING
-Doxycyclinepowder69988-0020DRUG FOR FURTHER PROCESSING
-Efavirenzpowder69988-0008DRUG FOR FURTHER PROCESSING
-Ergotamine Tartrate Caffienepowder69988-0023DRUG FOR FURTHER PROCESSING
-Erithromycinpowder69988-0004DRUG FOR FURTHER PROCESSING
-Estradiolpowder69989-0007DRUG FOR FURTHER PROCESSING
-Exemestranepowder69988-0010DRUG FOR FURTHER PROCESSING
-Felbamatepowder69988-0032DRUG FOR FURTHER PROCESSING
-Fentanyl Basepowder69988-0015DRUG FOR FURTHER PROCESSING
-Fluorourcilpowder69988-0043DRUG FOR FURTHER PROCESSING
-Gentamicin Sulfatepowder69988-0065DRUG FOR FURTHER PROCESSING
-Ibutinibpowder69988-0040DRUG FOR FURTHER PROCESSING
-Isradipinepowder69988-0012DRUG FOR FURTHER PROCESSING
-Letrozolepowder69988-0014DRUG FOR FURTHER PROCESSING
-Levalbuterol Tartratepowder69988-0045DRUG FOR FURTHER PROCESSING
-Mavacamtenpowder69988-0060DRUG FOR FURTHER PROCESSING
-Mifepristonepowder69989-0003DRUG FOR FURTHER PROCESSING
-Morphine Sulfatepowder69988-0036DRUG FOR FURTHER PROCESSING
-Neomycin Sulfatepowder69988-0031DRUG FOR FURTHER PROCESSING
-Nepafenacpowder69988-0005DRUG FOR FURTHER PROCESSING
-Olmesartan Medoxomilpowder69988-0063DRUG FOR FURTHER PROCESSING
-Oxycodone Hydrochloridepowder69988-0034DRUG FOR FURTHER PROCESSING
-Oxycodone basepowder69988-0037DRUG FOR FURTHER PROCESSING
-Palovarotenepowder69988-0055DRUG FOR FURTHER PROCESSING
-Phenoxybenzaminepowder69988-0016DRUG FOR FURTHER PROCESSING
-Pilocarpinepowder69988-0018DRUG FOR FURTHER PROCESSING
-Promethazine Hydrochloridepowder69988-0022DRUG FOR FURTHER PROCESSING
-Resmetirompowder69988-0061DRUG FOR FURTHER PROCESSING
-Resmetirompowder69988-0062DRUG FOR FURTHER PROCESSING
-Rimegepantpowder69989-0009DRUG FOR FURTHER PROCESSING
-Rimegepantpowder69989-0010DRUG FOR FURTHER PROCESSING
-Rimegepantpowder69989-0011DRUG FOR FURTHER PROCESSING
-Rimegepantpowder69989-0012DRUG FOR FURTHER PROCESSING
-Rimegepantpowder69989-0013DRUG FOR FURTHER PROCESSING
-Tafamidispowder69988-0039DRUG FOR FURTHER PROCESSING
-Vandetanibpowder69988-0054DRUG FOR FURTHER PROCESSING
-Zuranolonepowder69988-0059DRUG FOR FURTHER PROCESSING
-amifampridine phosphatepowder69988-0053DRUG FOR FURTHER PROCESSING
Compare

Other companies listing rimegepant

Enquiry

Common questions

Is Catalent Micron Technologies Limited FDA approved?
Catalent Micron Technologies Limited holds no registered establishment of its own; 49 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Catalent Micron Technologies Limited make?
49 products are listed under Catalent Micron Technologies Limited in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.